Development and application of a novel tracer system for the evaluation of temperature exposure of lipid nanoparticles in spray drying and dual centrifugation.
{"title":"Development and application of a novel tracer system for the evaluation of temperature exposure of lipid nanoparticles in spray drying and dual centrifugation.","authors":"Isabelle Klein, Denise Steiner","doi":"10.1016/j.ejpb.2025.114889","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, the development of nanocarriers and nanoscale drug delivery systems has become increasingly important, with temperature-intensive processes being an essential part of their preparation and following process steps. This study introduced a novel nanoparticular tracer system to track the highest temperatures to which the particles are exposed to during processing by exploiting the monotropic polymorphism of triglycerides. These nanoparticulate systems enabled an estimation of the temperature exposure of formulations in processes that are otherwise inaccessible or very difficult to access. Two tracer systems were developed using the solid lipids tristearin and tripalmitin, with distinct melting temperatures, and applied for the high-energy processes of spray drying and dual centrifugation. In addition, the experiments provided insights into the effect of stabilizers on triglyceride modifications. It was shown that during spray drying, the highest temperature exposure of the nanoparticles during the process was 4.1 °C and 6.6 °C for tristearin and tripalmitin, respectively, above the outlet air temperature of the spray dryer. In addition, the tristearin tracer system was used to investigate the temperature exposure during dual centrifugation, which indicated that with increasing process time of up to 480 min, all particles were progressively exposed to temperatures above their melting temperature.</p>","PeriodicalId":12024,"journal":{"name":"European Journal of Pharmaceutics and Biopharmaceutics","volume":" ","pages":"114889"},"PeriodicalIF":4.3000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutics and Biopharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejpb.2025.114889","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
In recent years, the development of nanocarriers and nanoscale drug delivery systems has become increasingly important, with temperature-intensive processes being an essential part of their preparation and following process steps. This study introduced a novel nanoparticular tracer system to track the highest temperatures to which the particles are exposed to during processing by exploiting the monotropic polymorphism of triglycerides. These nanoparticulate systems enabled an estimation of the temperature exposure of formulations in processes that are otherwise inaccessible or very difficult to access. Two tracer systems were developed using the solid lipids tristearin and tripalmitin, with distinct melting temperatures, and applied for the high-energy processes of spray drying and dual centrifugation. In addition, the experiments provided insights into the effect of stabilizers on triglyceride modifications. It was shown that during spray drying, the highest temperature exposure of the nanoparticles during the process was 4.1 °C and 6.6 °C for tristearin and tripalmitin, respectively, above the outlet air temperature of the spray dryer. In addition, the tristearin tracer system was used to investigate the temperature exposure during dual centrifugation, which indicated that with increasing process time of up to 480 min, all particles were progressively exposed to temperatures above their melting temperature.
期刊介绍:
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.
Topics covered include for example:
Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
Aspects of manufacturing process design
Biomedical aspects of drug product design
Strategies and formulations for controlled drug transport across biological barriers
Physicochemical aspects of drug product development
Novel excipients for drug product design
Drug delivery and controlled release systems for systemic and local applications
Nanomaterials for therapeutic and diagnostic purposes
Advanced therapy medicinal products
Medical devices supporting a distinct pharmacological effect.